NEW DELHI: The Central Industrial Security Force (CISF) will take over security of the Hyderabad campus of Bharat Biotech, the manufacturer of made-in-India Covid vaccine Covaxin, from June 14, official sources said.
Second made-in-India COVID vaccine: Centre seals deal with Biological-E for 30 crore doses
Times Now |
Embed
The health ministry has finalised arrangements with Hyderabad-based vaccine manufacturer Biological-E to book 30 crore COVID-19 vaccine doses, set to be manufactured and stockpiled from August to December this year. As per a health ministry statement on Thursday, an advance payment of Rs 1,500 crore will be made to Biological-E from the Centre. This is the second made-in-India vaccine after Bharat Biotech s COVAXIN. Biological-E s COVID-19 vaccine, an RBD protein sub-unit vaccine, is currently undergoing Phase-3 clinical trials.
Aiming at a stiff vaccination target, the government has booked 30 crore doses of Hyderabad-based Biological-E's Covid vaccine, which is still in clinical trials.